openPR Logo
Press release

Ureter Cancer (Oncology) pipeline Forecast Report, H1, 2017 – Pharmaceutical Pipeline Report

05-31-2017 04:02 PM CET | Health & Medicine

Press release from: Business and Banking Research Reports [MRH]

Market Research Hub

Market Research Hub

Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Ureter Cancer - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Ureter Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1070439

Ureter cancer or ureteral cancer is cancer of the ureter. Symptoms and signs of urethral cancer include bleeding from the urethra or blood in the urine, discharge from the urethra and enlarged lymph nodes in the groin area. Risk factors include smoking. Treatment includes surgery, chemotherapy and radiation therapy.

The Ureter Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Ureter Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II and Phase I stages are 3, 2 and 2 respectively. Similarly, the Universities portfolio in Phase I stages comprises 1 molecules, respectively.

Ureter Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Market Research Hubs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Ureter Cancer (Oncology).
- The pipeline guide reviews pipeline therapeutics for Ureter Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Ureter Cancer (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Ureter Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Ureter Cancer (Oncology)

Browse Full Report with TOC @ http://www.marketresearchhub.com/report/ureter-cancer-pipeline-review-h1-2017-report.html

Reasons to Buy:

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Ureter Cancer (Oncology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Ureter Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents:
List of Tables
List of Figures
Introduction
Market Research Hub Report Coverage
Ureter Cancer - Overview
Ureter Cancer - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Ureter Cancer - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Ureter Cancer - Companies Involved in Therapeutics Development
Altor BioScience Corp
Eisai Co Ltd
Exelixis Inc
GlaxoSmithKline Plc
MedImmune LLC
Merck & Co Inc
Ureter Cancer - Drug Profiles
ALT-801 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
cabozantinib s-malate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
durvalumab - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
durvalumab + tremelimumab - Drug Profile
Product Description
Mechanism Of Action

About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Details:
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/
Follow Us on:
Twitter: https://twitter.com/MktResearchHub/
LinkedIn: https://www.linkedin.com/company/market-research-hub/
Facebook: https://www.facebook.com/MarketResearchHub/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ureter Cancer (Oncology) pipeline Forecast Report, H1, 2017 – Pharmaceutical Pipeline Report here

News-ID: 558422 • Views:

More Releases from Business and Banking Research Reports [MRH]

Russian Accident and health insurance industry Comprehensive Outlook, Key Trends and Opportunities until 2020
Russian Accident and health insurance industry Comprehensive Outlook, Key Trends …
Market Research Hub (MRH) added a new research report to its vast database titled “Accident and Health insurance in Russia, Key Trends and Opportunities to 2020” which provides a detailed outlook by product category for the Russian accident and health insurance segment, and a comparison of the Russian insurance industry with its regional counterparts. Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1328144 It provides key performance indicators such as written premium, incurred loss, loss
Russian Life Insurance industry Comprehensive Outlook, Key Trends and Opportunities until 2020
Russian Life Insurance industry Comprehensive Outlook, Key Trends and Opportunit …
Market Research Hub (MRH) added a new research report to its vast database titled “Life Insurance in Russia, Key Trends and Opportunities to 2020” which provides a detailed outlook by product category for the Russian life insurance segment, and a comparison of the Russian Life insurance industry with its regional counterparts. Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1328142 The report provides key performance indicators such as written premium, incurred loss, loss ratio, commissions
Latvian Insurance Industry Market Trends, Drivers, Challenges, Opportunities Until 2020
Latvian Insurance Industry Market Trends, Drivers, Challenges, Opportunities Unt …
Market Research Hub (MRH) has included a new research report titled “The Insurance Industry in Latvia Key Trends and Opportunities to 2021”, which provides values for key performance indicators such as written premium, incurred loss, loss ratio, commissions and expenses, combined ratio, total assets, total investment income and retentions during the review period (2011-2015) and forecast period (2016-2020). Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1328139 The report also analyzes distribution channels operating in
EMEA Gusseted Bags Market Outlook Offers Analysis on Emerging Trends and Growth Factors Forecasted till 2022
EMEA Gusseted Bags Market Outlook Offers Analysis on Emerging Trends and Growth …
A fresh report has been added to the wide database of Market Research Hub (MRH). The research study is titled “EMEA Gusseted Bags Market Report” which encloses important data about the production, consumption, revenue and market share, merged with information related to the market scope and product overview. The report anticipates that the sector for Retail would rise at a positive CAGR during the period 2017-2022. Request For Free Sample -

All 5 Releases


More Releases for Ureter

Ureter Cancer Treatment Market Key Manufacturers, Development Trends and Competi …
Ureter cancer or renal pelvis cancer represents a cancer type affecting the kidney's pelvis (tube passing the urine from kidney to the bladder). These cancers account for around five percent of all the cancer types related to upper urinary tract and kidney. The occurrence of ureter cancer is more common in men (aged more than 65 years) than women. Ureter or renal pelvis cancer tumors are usually transitional cell cancers
Bladder and Ureter Cancer Drug Global Market Research Report 2019
Bladder and Ureter Cancer Drug Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/bladder-and-ureter-cancer-drug-market/80853 The report firstly introduced the Bladder and Ureter Cancer Drug
Comprehensive Information and Insights on the Bladder and Ureter Cancer Drug Dev …
The study offers an overall synopsis of the ureter and the bladder drug development pipeline scenario. The research publication also presents wide ranging information on therapeutics under development as well as leading competitors associated with this sector along with the information on the projects that have been discontinued and the therapeutic growth for the two indications. The research publication titled "Bladder and Ureter Cancer Drug Development Pipeline Analysis, 2017" has
Latest Survey Reveals Bladder and Ureter Cancer Drug Development Pipeline Review …
Researchmoz added Most up-to-date research on "Bladder and Ureter Cancer Drug Development Pipeline Review, 2017" to its huge collection of research reports. This report provides an overview of the bladder and ureter pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for these two indications, and features dormant and discontinued projects. Bladder cancer occurs in tissues of the urinary bladder. Symptoms include
Ureter Cancer Treatment Market : Set for Rapid Growth
Ureter cancer or renal pelvis cancer represents a cancer type affecting the kidney’s pelvis (tube passing the urine from kidney to the bladder). These cancers account for around five percent of all the cancer types related to upper urinary tract and kidney. The occurrence of ureter cancer is more common in men (aged more than 65 years) than women. Ureter or renal pelvis cancer tumors are usually transitional cell cancers
Global Ureter Cancer Drugs Sales Market Size, Analysis and Growth, Trends Foreca …
To Understand the pharmaceutical Industry Status worldwide, Market Research Hub (MRH) has included the recent Forecast report titled “Global Ureter Cancer Drugs Sales Market Report 2017”, to its vast database. This study offers data about the prime regions operating in the pharmaceutical sector, along with their production, consumption, revenue and market share details. Further, the intelligent report also anticipates that the market would grow at a constructive CAGR until 2022. Click